Stock BWXT BWX TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News BWX Technologies, Inc.

Equities

BWXT

US05605H1005

Delayed Nyse
Other stock markets
 01:00:02 2024-07-03 pm EDT 		5-day change 1st Jan Change
95.47 USD +1.27% Intraday chart for BWX Technologies, Inc. -0.02% +24.42%
Jun. 27 Janney Initiates BWX Technologies at Buy With $113 Price Target MT
Jun. 26 BTIG Research Initiates Coverage on BWX Technologies With Buy Rating, $110 Price Target MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BWX Technologies to Announce Second Quarter 2024 Results on Monday, August 5
BU
Janney Initiates BWX Technologies at Buy With $113 Price Target
MT
BTIG Research Initiates Coverage on BWX Technologies With Buy Rating, $110 Price Target
MT
BWX Technologies Wins Phase 2 Contract of Wyoming's Microreactor Evaluation Program
MT
BWX Technologies Wins Microreactor-Evaluation Pact for Wyoming
DJ
BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming
BU
BWX Technologies, Inc Awards Phase Two of Microreactor Evaluation Contract for State of Wyoming
CI
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant
AQ
Sector Update: Energy Stocks Decline in Late Friday Afternoon Trading
MT
Sector Update: Energy Stocks Fall in Friday Afternoon Trading
MT
Sector Update: Energy
MT
BWX Technologies JV PanTeXas Deterrence Awarded Contract Worth up to $30 Billion to Safeguard US Nuclear Weapons
MT
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration’s Pantex Plant
BU
BWX Technologies, Inc. Wins $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant
CI
Deutsche Bank Adjusts BWX Technologies Price Target to $107 From $110, Maintains Buy Rating
MT
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration
AQ
BWX Technologies' Unit Submits Drug Master File for Actinium-225 to FDA
MT
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration
BU
BWX Technologies : BWXT employees trained as Nuclear Ambassadors
PU
Ex-dividend day
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BWXT Stock
  4. News BWX Technologies, Inc.